Cargando…

Risk–benefit assessment of seaweed Allergenicity risk assessment of novel protein

As the world population rapidly grows, there is a clear need for alternative food sources, particularly for the provision of protein. Seaweed is one such alternative source of protein that requires greater investigation. In this context, a working programme within the European Food Risk Assessment (...

Descripción completa

Detalles Bibliográficos
Autores principales: Garciarena, Irene Nuin, Poulsen, Morten, Lindholm Bøgh, Katrine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131616/
https://www.ncbi.nlm.nih.gov/pubmed/35634551
http://dx.doi.org/10.2903/j.efsa.2022.e200414
_version_ 1784713211001438208
author Garciarena, Irene Nuin
Poulsen, Morten
Lindholm Bøgh, Katrine
author_facet Garciarena, Irene Nuin
Poulsen, Morten
Lindholm Bøgh, Katrine
author_sort Garciarena, Irene Nuin
collection PubMed
description As the world population rapidly grows, there is a clear need for alternative food sources, particularly for the provision of protein. Seaweed is one such alternative source of protein that requires greater investigation. In this context, a working programme within the European Food Risk Assessment (EU‐FORA) Fellowship Programme framework was developed at National Food Institute – Technical University of Denmark. This Programme is an initiative of the EFSA with the aim to build a European risk assessment community. The purpose of this technical report is to describe the activities in which the fellow was involved. As part of the Research Group for Risk–Benefit, the fellow performed a risk–benefit assessment of seaweed Palmaria palmata gaining an in‐depth expertise in all the steps. The health impact of Palmaria palmata consumption was estimated, considering its high nutritional value but also highlighting concerns towards some components. Simultaneous to the work on the risk–benefit, the fellow also worked within the Research Group for Food Allergy, specifically on the allergenicity risk assessment of a plant‐based novel protein (seaweed protein) using different laboratory assays. Seaweed protein digestibility was assessed, and its digestion products were characterised and assessed for immunogenicity. Finally, the fellow collaborated with the Research Group for Microbial Biotechnology and Biorefining in the development of a novel food (alfalfa protein) application dossier to be submitted to EFSA, gaining expertise in the risk assessment of a novel food. In conclusion, the present working programme, together with additional activities and training provided by different institutions, enabled the fellow to gain a broader perspective in food safety, particularly concerning seaweed, novel foods and the safety assessment of novel proteins.
format Online
Article
Text
id pubmed-9131616
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-91316162022-05-26 Risk–benefit assessment of seaweed Allergenicity risk assessment of novel protein Garciarena, Irene Nuin Poulsen, Morten Lindholm Bøgh, Katrine EFSA J Eu‐fora Series 4 As the world population rapidly grows, there is a clear need for alternative food sources, particularly for the provision of protein. Seaweed is one such alternative source of protein that requires greater investigation. In this context, a working programme within the European Food Risk Assessment (EU‐FORA) Fellowship Programme framework was developed at National Food Institute – Technical University of Denmark. This Programme is an initiative of the EFSA with the aim to build a European risk assessment community. The purpose of this technical report is to describe the activities in which the fellow was involved. As part of the Research Group for Risk–Benefit, the fellow performed a risk–benefit assessment of seaweed Palmaria palmata gaining an in‐depth expertise in all the steps. The health impact of Palmaria palmata consumption was estimated, considering its high nutritional value but also highlighting concerns towards some components. Simultaneous to the work on the risk–benefit, the fellow also worked within the Research Group for Food Allergy, specifically on the allergenicity risk assessment of a plant‐based novel protein (seaweed protein) using different laboratory assays. Seaweed protein digestibility was assessed, and its digestion products were characterised and assessed for immunogenicity. Finally, the fellow collaborated with the Research Group for Microbial Biotechnology and Biorefining in the development of a novel food (alfalfa protein) application dossier to be submitted to EFSA, gaining expertise in the risk assessment of a novel food. In conclusion, the present working programme, together with additional activities and training provided by different institutions, enabled the fellow to gain a broader perspective in food safety, particularly concerning seaweed, novel foods and the safety assessment of novel proteins. John Wiley and Sons Inc. 2022-05-25 /pmc/articles/PMC9131616/ /pubmed/35634551 http://dx.doi.org/10.2903/j.efsa.2022.e200414 Text en © 2022 Wiley‐VCH Verlag GmbH & Co. KgaA on behalf of the European Food Safety Authority. https://creativecommons.org/licenses/by-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nd/4.0/ (https://creativecommons.org/licenses/by-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited and no modifications or adaptations are made.
spellingShingle Eu‐fora Series 4
Garciarena, Irene Nuin
Poulsen, Morten
Lindholm Bøgh, Katrine
Risk–benefit assessment of seaweed Allergenicity risk assessment of novel protein
title Risk–benefit assessment of seaweed Allergenicity risk assessment of novel protein
title_full Risk–benefit assessment of seaweed Allergenicity risk assessment of novel protein
title_fullStr Risk–benefit assessment of seaweed Allergenicity risk assessment of novel protein
title_full_unstemmed Risk–benefit assessment of seaweed Allergenicity risk assessment of novel protein
title_short Risk–benefit assessment of seaweed Allergenicity risk assessment of novel protein
title_sort risk–benefit assessment of seaweed allergenicity risk assessment of novel protein
topic Eu‐fora Series 4
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131616/
https://www.ncbi.nlm.nih.gov/pubmed/35634551
http://dx.doi.org/10.2903/j.efsa.2022.e200414
work_keys_str_mv AT garciarenairenenuin riskbenefitassessmentofseaweedallergenicityriskassessmentofnovelprotein
AT poulsenmorten riskbenefitassessmentofseaweedallergenicityriskassessmentofnovelprotein
AT lindholmbøghkatrine riskbenefitassessmentofseaweedallergenicityriskassessmentofnovelprotein